Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heavy metals and toxins in the gastrointestinal lumen refer to a diverse array of harmful substances, including environmental pollutants like lead and mercury, as well as biological toxins produced by pathogens such as Clostridioides difficile [1][2]. While not traditional molecular targets like receptors or enzymes, these substances are the focus of therapeutic intervention aimed at preventing their absorption into the systemic circulation [3]. The primary strategy involves the use of oral agents that sequester these toxins within the gut, facilitating their eventual elimination through feces [4]. For instance, activated charcoal provides a large surface area for the non-specific adsorption of various chemicals, while specific resins like Prussian blue are used to bind heavy metals like thallium [1][5]. Managing the luminal toxic load is essential for treating acute intoxications, mitigating the effects of chronic environmental exposure, and reducing the systemic burden of uremic toxins in patients with renal impairment [6]. By neutralizing these agents before they cross the intestinal barrier, clinicians can prevent widespread organ damage and systemic toxicity [2].
Drugs targeting these substances work through physical adsorption, chemical chelation, or ion exchange to sequester toxins within the gastrointestinal tract, preventing their systemic absorption and facilitating fecal excretion [1][3][4].
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heavy metals and toxins in the gastrointestinal lumen.